Navigation Links
Hospira Expands Board of Directors
Date:8/17/2011

LAKE FOREST, Ill., Aug. 17, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that William G. Dempsey has been elected to the company's board of directors. Dempsey brings strong executive management and diverse global experience from leadership positions held in the healthcare industry. The addition of Dempsey expands Hospira's board to 11 directors, nine of whom are independent.

(Logo:  http://photos.prnewswire.com/prnh/20040503/HSPLOGO)

"Bill understands how to successfully grow a large, multinational healthcare business," said Christopher B. Begley, executive chairman. "His impressive track record of results-oriented leadership and operational experience in the healthcare field makes him an excellent fit for the Hospira board."

John C. Staley, Hospira's lead director, added, "We are excited to welcome Bill to Hospira's board of directors. His broad and deep knowledge of global healthcare markets enhances our current board membership and supports Hospira's goals for international expansion."

Dempsey, 59, spent more than two decades at Abbott Laboratories, most recently serving as executive vice president, Global Pharmaceuticals, where he was responsible for the company's $14 billion global pharmaceutical business, representing more than 33,000 employees. In this position, from which he retired in 2007, he drove the business to 15 percent growth in revenues and profitability in the face of major new generic competition. He also led an initiative that doubled research and development productivity over three years, and negotiated and integrated the successful $3.7 billion acquisition of the cardiovascular company, Kos Pharmaceuticals.

From 2003 to 2006, Dempsey was Abbott's senior vice president, Pharmaceutical Operations, responsible for Abbott's $8 billion U.S. pharmaceuticals business. In this role, Dempsey consistently delivered strong sales growth and successfully launched the blockbuster rheumatoid arthritis drug Humira.

Previously, Dempsey was Abbott's senior vice president, International Operations, where he served from 1999 to 2003, managing all of Abbott's pharmaceutical, hospital and nutritional businesses outside the United States. During his tenure, he grew the business from approximately $3 billion in sales to $5 billion in sales.

In prior roles at Abbott, Dempsey served as senior vice president, Chemical and Agricultural Products, and vice president, Hospital Products Business Sector, among other positions. Before working at Abbott, Dempsey served in various roles at Sciaky Brothers Inc. and Crane Company.

Dempsey currently serves on the boards of Landauer, Inc. and Nordion, Inc. A native of Chicago, Ill., he holds a Bachelor of Science degree from DePaul University.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
2. Hospira Reports Second-Quarter 2011 Results
3. Hospira to Host Conference Call for Second-Quarter 2011 Results
4. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
5. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
6. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
7. Hospira Reports First-Quarter 2011 Results
8. Hospira Board Authorizes $1 Billion Share Repurchase Program
9. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
10. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
11. Hospira to Host Conference Call for First-Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
(Date:6/24/2016)... Washington, D.C. (PRWEB) , ... June 24, 2016 , ... ... Pro-Am Heroes Golf Classic Tournament held on June 20th at the Woodmont Country ... local charity, Luke’s Wings, an organization dedicated to helping service members that have been ...
Breaking Medicine News(10 mins):